Skip to main content
. Author manuscript; available in PMC: 2020 Aug 2.
Published in final edited form as: Clin Cancer Res. 2018 Mar 13;24(12):2820–2827. doi: 10.1158/1078-0432.CCR-17-2940

Figure 4. EPICOLON I. Disease Free Survival Stages II and III CRC. TFAP2E Methylation.

Figure 4.

Disease Free Survival of patients with stage II and III disease during FU (follow-up) that received (A) or did not receive (B) adjuvant chemotherapy according to TFAP2E methylation status. (C) Disease Free Survival of patients with stage II+III CRC and TFAP2E methylated and (D) TFAP2E non-methylated tumors (E) Disease Free Survival of patients with stage III CRC and TFAP2E methylated and (F) TFAP2E non-methylated tumors.